Citadel Advisors’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.8M | Buy |
1,150,018
+894,667
| +350% | +$21.2M | ﹤0.01% | 1907 |
|
|
2025
Q4 | $6.72M | Buy |
255,351
+48,493
| +23% | +$1.06M | ﹤0.01% | 3835 |
|
|
2025
Q3 | $3.53M | Sell |
206,858
-39,297
| -16% | -$562K | ﹤0.01% | 4992 |
|
|
2025
Q2 | $3.09M | Buy |
246,155
+65,485
| +36% | +$780K | ﹤0.01% | 4928 |
|
|
2025
Q1 | $2.15M | Buy |
180,670
+122,312
| +210% | +$1.67M | ﹤0.01% | 5388 |
|
|
2024
Q4 | $854K | Buy |
58,358
+37,550
| +180% | +$525K | ﹤0.01% | 7386 |
|
|
2024
Q3 | $261K | Sell |
20,808
-578,574
| -97% | -$6.3M | ﹤0.01% | 9596 |
|
|
2024
Q2 | $5.1M | Sell |
599,382
-465,605
| -44% | -$4.14M | ﹤0.01% | 3719 |
|
|
2024
Q1 | $11.2M | Buy |
1,064,987
+891,414
| +514% | +$9.9M | ﹤0.01% | 2804 |
|
|
2023
Q4 | $1.8M | Buy |
173,573
+136,567
| +369% | +$1.09M | ﹤0.01% | 5546 |
|
|
2023
Q3 | $235K | Sell |
37,006
-16,113
| -30% | -$119K | ﹤0.01% | 9616 |
|
|
2023
Q2 | $459K | Sell |
53,119
-1,362
| -2% | -$12.2K | ﹤0.01% | 8136 |
|
|
2023
Q1 | $493K | Buy |
54,481
+53,612
| +6,169% | +$468K | ﹤0.01% | 8352 |
|
|
2022
Q4 | $6.83K | Sell |
869
-122,458
| -99% | -$861K | ﹤0.01% | 13880 |
|
|
2022
Q3 | $758K | Sell |
123,327
-54,197
| -31% | -$327K | ﹤0.01% | 7591 |
|
|
2022
Q2 | $941K | Sell |
177,524
-106,380
| -37% | -$643K | ﹤0.01% | 7159 |
|
|
2022
Q1 | $1.86M | Buy |
283,904
+229,379
| +421% | +$2.04M | ﹤0.01% | 6247 |
|
|
2021
Q4 | $894K | Buy |
54,525
+27,832
| +104% | +$580K | ﹤0.01% | 8226 |
|
|
2021
Q3 | $775K | Buy |
26,693
+16,798
| +170% | +$558K | ﹤0.01% | 8793 |
|
|
2021
Q2 | $343K | Sell |
9,895
-133,216
| -93% | -$4.23M | ﹤0.01% | 10945 |
|
|
2021
Q1 | $4.52M | Buy |
143,111
+40,288
| +39% | +$1.64M | ﹤0.01% | 4475 |
|
|
2020
Q4 | $4.86M | Sell |
102,823
-596,614
| -85% | -$27.7M | ﹤0.01% | 3736 |
|
|
2020
Q3 | $32.6M | Sell |
699,437
-219,013
| -24% | -$7.52M | 0.01% | 1157 |
|
|
2020
Q2 | $33.1M | Buy |
918,450
+492,964
| +116% | +$18.2M | 0.01% | 1083 |
|
|
2020
Q1 | $15.1M | Buy |
425,486
+96,348
| +29% | +$3.94M | 0.01% | 1470 |
|
|
2019
Q4 | $15M | Buy |
+329,138
| New | +$12M | 0.01% | 1769 |
|
|
2019
Q3 | – | Sell |
-11,754
| Closed | -$259K | – | 9845 |
|
|
2019
Q2 | $259K | Sell |
11,754
-1,282
| -10% | -$23.5K | ﹤0.01% | 7814 |
|
|
2019
Q1 | $211K | Buy |
13,036
+606
| +5% | +$9.4K | ﹤0.01% | 8138 |
|
|
2018
Q4 | $182K | Buy |
+12,430
| New | +$163K | ﹤0.01% | 7937 |
|
|
2018
Q1 | – | Sell |
-11,610
| Closed | -$88K | – | 8872 |
|
|
2017
Q4 | $88K | Buy |
+11,610
| New | +$95.4K | ﹤0.01% | 7474 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
NI
Citadel Advisors's ZYME Position: Q1 2026 in Review
Citadel Advisors increased its Zymeworks (ZYME) stake by 350% in Q1 2026, buying an estimated $21.2M and bringing the position to 1,150,018 shares worth $28.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1907.
Citadel Advisors first reported a position in ZYME in Q4 2017 and has held it in 30 quarters since. The position peaked at $33.1M in Q2 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Citadel Advisors held 1,150,018 shares of Zymeworks worth $28.8M as of Q1 2026.
- Citadel Advisors bought 894,667 Zymeworks shares in Q1 2026, an estimated $21.2M.
- Zymeworks made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #1907 holding.
- Citadel Advisors first reported a position in Zymeworks in Q4 2017 and has held it in 30 quarters since.
- Citadel Advisors's Zymeworks position peaked at $33.1M in Q2 2020.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.